EMN · Eastman Chemical Co - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $8.75B | $9.38B | $9.21B | $10.58B | $10.48B | $8.47B |
| Cost of Revenue | $6.91B | $7.09B | $7.15B | $8.44B | $7.98B | $6.50B |
| Gross Profit | $1.84B | $2.29B | $2.06B | $2.14B | $2.50B | $1.98B |
| R&D | $255.00M | $250.00M | $239.00M | $264.00M | $254.00M | $226.00M |
| SG&A | $658.00M | $736.00M | $727.00M | $726.00M | $795.00M | $654.00M |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $513.00M | $509.00M | $498.00M | $477.00M | $538.00M | $574.00M |
| Operating Income | $568.00M | $1.08B | $1.09B | $977.00M | $1.08B | $530.00M |
| Interest Expense | - | - | - | - | - | - |
| Income Tax | $93.00M | $170.00M | $191.00M | $181.00M | $215.00M | $41.00M |
| Net Income | $474.00M | $905.00M | $894.00M | $793.00M | $857.00M | $478.00M |
| EPS - Basic | $4.14 | $7.75 | $7.54 | $6.42 | $6.35 | $3.53 |
| EPS - Diluted | $4.10 | $7.67 | $7.49 | $6.35 | $6.25 | $3.50 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $566.00M | $837.00M | $548.00M | $493.00M | $459.00M | $564.00M |
| Accounts Receivable | $737.00M | $791.00M | $826.00M | $957.00M | $1.09B | $1.03B |
| Inventory | $1.98B | $1.99B | $1.68B | $1.89B | $1.50B | $1.38B |
| Accounts Payable | $1.21B | $1.31B | $1.17B | $1.32B | $1.23B | $799.00M |
| Current Assets | $3.65B | $4.10B | $3.48B | $3.78B | $4.65B | $3.54B |
| Total Assets | $14.86B | $15.21B | $14.63B | $14.67B | $15.52B | $16.08B |
| Current Liabilities | $2.65B | $2.71B | $2.58B | $3.25B | $2.97B | $2.04B |
| Long-term Debt | $4.20B | $4.57B | $4.30B | $4.03B | $4.41B | $5.27B |
| Total Liabilities | $8.82B | $9.36B | $9.10B | $9.43B | $9.73B | $9.97B |
| Stockholders' Equity | $5.96B | $5.78B | $5.46B | $5.15B | $5.70B | $6.02B |
| Retained Earnings | $10.11B | $10.01B | $9.49B | $8.97B | $8.56B | $8.08B |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $970.00M | $1.29B | $1.37B | $975.00M | $1.62B | $1.46B |
| Investing Cash Flow | ($462.00M) | ($534.00M) | ($432.00M) | $392.00M | ($29.00M) | ($394.00M) |
| Financing Cash Flow | ($797.00M) | ($454.00M) | ($888.00M) | ($1.32B) | ($1.69B) | ($704.00M) |
| CapEx | $546.00M | $599.00M | $828.00M | $611.00M | $555.00M | $383.00M |
| Free Cash Flow | $424.00M | $688.00M | $546.00M | $364.00M | $1.06B | $1.07B |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 21.1% | 24.4% | 22.4% | 20.2% | 23.9% | 23.3% |
| Operating margin | 6.5% | 11.5% | 11.8% | 9.2% | 10.3% | 6.3% |
| EBITDA margin | 12.4% | 16.9% | 17.2% | 13.7% | 15.5% | 13.0% |
| Net margin | 5.4% | 9.6% | 9.7% | 7.5% | 8.2% | 5.6% |
| Free cash flow margin | 4.8% | 7.3% | 5.9% | 3.4% | 10.2% | 12.7% |
| FCF / Net income | 0.89 | 0.76 | 0.61 | 0.46 | 1.24 | 2.24 |
| R&D / Revenue | 2.9% | 2.7% | 2.6% | 2.5% | 2.4% | 2.7% |
| SG&A / Revenue | 7.5% | 7.8% | 7.9% | 6.9% | 7.6% | 7.7% |
| Effective tax rate | 16.4% | 15.8% | 17.6% | 18.6% | 20.1% | 7.9% |
| Return on assets | 3.2% | 5.9% | 6.1% | 5.4% | 5.5% | 3.0% |
| Return on equity | 8.0% | 15.7% | 16.4% | 15.4% | 15.0% | 7.9% |
| Return on invested capital | 4.7% | 8.8% | 9.2% | 8.7% | 8.6% | 4.3% |
| Liquidity | ||||||
| Current ratio | 1.37 | 1.51 | 1.35 | 1.16 | 1.56 | 1.74 |
| Quick ratio | 0.63 | 0.78 | 0.70 | 0.58 | 1.06 | 1.06 |
| Cash ratio | 0.21 | 0.31 | 0.21 | 0.15 | 0.15 | 0.28 |
| Leverage | ||||||
| Debt / Equity | 0.70 | 0.79 | 0.79 | 0.78 | 0.77 | 0.87 |
| Debt / Assets | 0.28 | 0.30 | 0.29 | 0.27 | 0.28 | 0.33 |
| Debt / EBITDA | 3.89 | 2.88 | 2.72 | 2.77 | 2.72 | 4.77 |
| Interest coverage | - | - | - | - | - | - |
| Equity multiplier | 2.49 | 2.63 | 2.68 | 2.85 | 2.72 | 2.67 |
| Liabilities / Assets | 0.59 | 0.62 | 0.62 | 0.64 | 0.63 | 0.62 |
| Efficiency | ||||||
| Asset turnover | 0.59 | 0.62 | 0.63 | 0.72 | 0.68 | 0.53 |
| Inventory turnover | 3.49 | 3.57 | 4.25 | 4.46 | 5.30 | 4.71 |
| Days sales outstanding | 31d | 31d | 33d | 33d | 38d | 44d |
| Days inventory outstanding | 105d | 102d | 86d | 82d | 69d | 77d |
| Days payable outstanding | 64d | 67d | 60d | 57d | 56d | 45d |
| Cash conversion cycle | 71d | 66d | 59d | 58d | 51d | 77d |
| Valuation | ||||||
| P / E | 15.6x | 11.9x | 12.0x | 12.8x | 19.3x | 28.7x |
| P / B | 1.2x | 1.9x | 2.0x | 2.0x | 2.9x | 2.3x |
| P / S | 0.8x | 1.1x | 1.2x | 1.0x | 1.6x | 1.6x |
| EV / EBITDA | 10.2x | 9.1x | 9.1x | 9.4x | 12.7x | 16.7x |
| Growth | ||||||
| Revenue growth (YoY) | -6.7% | 1.9% | -12.9% | 1.0% | 23.6% | -8.6% |
| Revenue CAGR (3y) | -6.1% | -3.6% | 2.8% | 4.5% | 1.1% | -3.9% |
| Revenue CAGR (5y) | 0.7% | 0.2% | -1.9% | 2.1% | 3.1% | -2.6% |
| Gross profit growth (YoY) | -19.5% | 11.1% | -3.6% | -14.5% | 26.6% | -11.6% |
| Operating income growth (YoY) | -47.3% | -0.8% | 11.3% | -9.7% | 104.2% | -41.2% |
| Net income growth (YoY) | -47.6% | 1.2% | 12.7% | -7.5% | 79.3% | -37.0% |
| EPS growth (YoY) | -46.5% | 2.4% | 18.0% | 1.6% | 78.6% | -36.1% |
| EPS CAGR (3y) | -13.6% | 7.1% | 28.9% | 5.0% | -6.1% | -28.2% |
| EPS CAGR (5y) | 3.2% | 7.0% | -0.2% | -7.7% | 1.7% | -9.2% |
| FCF growth (YoY) | -38.4% | 26.0% | 50.0% | -65.8% | -0.7% | -0.6% |
| FCF CAGR (5y) | -16.9% | -8.6% | -11.7% | -18.4% | 7.0% | 2.2% |
| Book value growth (YoY) | 3.1% | 5.9% | 5.9% | -9.7% | -5.3% | 1.1% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$8.75B totalAdditives And Functional Products$2.88B · 32.9%
Advanced Materials$2.88B · 32.9%
Chemical Intermediates$1.93B · 22.0%
Fibers$1.05B · 12.0%
All Other Segments$17.00M · 0.2%
Geographic
$8.75B totalAll Foreign Countries$4.14B · 47.3%
US$3.66B · 41.8%
CN$950.00M · 10.9%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
1.61
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
5/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✗Current ratio improved
- ✓No share dilution
- ✗Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Plastic Materials, Synth Resins & Nonvulcan Elastomers
Comparing EASTMAN CHEMICAL CO against the 5 most active filers in the same SIC group.
Dividends
$3.34/share trailing 12 months · +1.8% YoY
| Ex-date | Per share |
|---|---|
| Mar 13, 2026 | $0.8400 |
| Dec 15, 2025 | $0.8400 |
| Sep 15, 2025 | $0.8300 |
| Jun 13, 2025 | $0.8300 |
| Mar 14, 2025 | $0.8300 |
| Dec 16, 2024 | $0.8300 |
| Sep 16, 2024 | $0.8100 |
| Jun 17, 2024 | $0.8100 |
| Mar 14, 2024 | $0.8100 |
| Dec 15, 2023 | $0.8100 |
| Sep 14, 2023 | $0.7900 |
| Jun 14, 2023 | $0.7900 |
| Mar 14, 2023 | $0.7900 |
| Dec 14, 2022 | $0.7900 |
| Sep 14, 2022 | $0.7600 |
| Jun 14, 2022 | $0.7600 |
| Mar 14, 2022 | $0.7600 |
| Dec 14, 2021 | $0.7600 |
| Sep 14, 2021 | $0.6900 |
| Jun 14, 2021 | $0.6900 |
| Mar 12, 2021 | $0.6900 |
| Dec 14, 2020 | $0.6900 |
| Sep 14, 2020 | $0.6600 |
| Jun 12, 2020 | $0.6600 |